Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1982 Oct;48(4):381–387. doi: 10.1136/hrt.48.4.381

Evaluation of drug-induced changes in myocardial repolarisation using the paced evoked response.

R M Donaldson, A F Rickards
PMCID: PMC481264  PMID: 7126390

Abstract

The use of the pace evoked response system in the assessment of drug-induced changes in myocardial repolarisation is reported. Using a conventional pacing electrode lead for both pacing and sensing, this system records the dominantly local repolarisation which follows a controlled (paced) depolarisation from the same site. Measurements of the latency of the ventricular evoked response at matched heart rates before and after drug administration permit the accurate direct comparison of the effects of drugs with class 3 mode of action on cardiac muscle repolarisation. Using this method we have evaluated the effect on the timing of the evoked T wave of two drugs which are known to prolong phase 2 of the action potential. Intravenous amiodarone (5 mg/kg) prolonged the stimulus-peak evoked T wave interval by an average of 39-4 ms (15% of control values); three hours after oral bethanidine (2 mg/kg) this interval increased by an average of 25.8 ms (10% of control values). The effect of therapeutic interventions on the latency of the local paced evoked response provides a simple, accurate assessment of their effect on the cellular action potential duration and constitutes a new tool in electrophysiological investigations.

Full text

PDF
381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amlie J. P., Refsum H., Landmark K. H. Prolonged ventricular refractoriness and action potential duration after beta-adrenoreceptor blockade in the dog heart in situ. J Cardiovasc Pharmacol. 1982 Jan-Feb;4(1):157–162. doi: 10.1097/00005344-198201000-00025. [DOI] [PubMed] [Google Scholar]
  2. Bigger J. T., Jr, Jaffe C. C. The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers. Am J Cardiol. 1971 Jan;27(1):82–92. doi: 10.1016/0002-9149(71)90086-5. [DOI] [PubMed] [Google Scholar]
  3. Cabasson J., Puech P., Mellet J. M., Guimond C., Bachy C., Sassine A. Analyse des effets électrophysiologiques de l'amiodarone par l'enregistrement simultané des potentiels d'action monophasiques et du faisceau de His. Arch Mal Coeur Vaiss. 1976 Jul;69(7):691–699. [PubMed] [Google Scholar]
  4. Cranefield P. F. Action potentials, afterpotentials, and arrhythmias. Circ Res. 1977 Oct;41(4):415–423. doi: 10.1161/01.res.41.4.415. [DOI] [PubMed] [Google Scholar]
  5. DOYLE A. E., MORLEY A. STUDIES ON THE ABSORPTION AND EXCRETION OF (14C)-BETHANIDINE IN MAN. Br J Pharmacol Chemother. 1965 Jun;24:701–704. doi: 10.1111/j.1476-5381.1965.tb01625.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HOFFMAN B. F., CRANEFIELD P. F., LEPESCHKIN E., SURAWICZ B., HERRLICH H. C. Comparison of cardiac monophasic action potentials recorded by intracellular and suction electrodes. Am J Physiol. 1959 Jun;196(6):1297–1301. doi: 10.1152/ajplegacy.1959.196.6.1297. [DOI] [PubMed] [Google Scholar]
  7. Holder D. A., Sniderman A. D., Fraser G., Fallen E. L. Experience with bretylium tosylate by a hospital cardiac arrest team. Circulation. 1977 Mar;55(3):541–544. doi: 10.1161/01.cir.55.3.541. [DOI] [PubMed] [Google Scholar]
  8. Ito S., Surawicz B. Effect of tetraethylammonium chloride on action potential in cardiac Purkinje fibers. Am J Physiol. 1981 Aug;241(2):H139–H144. doi: 10.1152/ajpheart.1981.241.2.H139. [DOI] [PubMed] [Google Scholar]
  9. Milne J. R., Camm A. J., Ward D. E., Spurrell R. A. Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J. 1980 Jan;43(1):1–6. doi: 10.1136/hrt.43.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Noble D., Tsien R. W. Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres. J Physiol. 1969 Jan;200(1):205–231. doi: 10.1113/jphysiol.1969.sp008689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Olsson B., Varnauskas E., Korsgren M. Further improved method for measuring monophasic action potentials of the intact human heart. J Electrocardiol. 1971;4(1):19–23. doi: 10.1016/s0022-0736(71)80045-6. [DOI] [PubMed] [Google Scholar]
  12. Olsson S. B., Brorson L., Varnauskas E. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973 Dec;35(12):1255–1259. doi: 10.1136/hrt.35.12.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Olsson S. B., Edvardsson N. Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation. Am Heart J. 1981 Nov;102(5):864–871. doi: 10.1016/0002-8703(81)90037-5. [DOI] [PubMed] [Google Scholar]
  14. Rickards A. F., Norman J. Relation between QT interval and heart rate. New design of physiologically adaptive cardiac pacemaker. Br Heart J. 1981 Jan;45(1):56–61. doi: 10.1136/hrt.45.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosen M. R., Hoffman B. F. Mechanisms of action of antiarrhythmic drugs. Circ Res. 1973 Jan;32(1):1–8. doi: 10.1161/01.res.32.1.1. [DOI] [PubMed] [Google Scholar]
  16. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  17. Samuelsson R. G., Harrison D. C. Electrophysiologic evaluation of encainide with use of monophasic action potential recording. Am J Cardiol. 1981 Nov;48(5):871–876. doi: 10.1016/0002-9149(81)90352-0. [DOI] [PubMed] [Google Scholar]
  18. Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Williams E. M., Hassan M. O., Floras J. S., Sleight P., Jones J. V. Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation. Br Heart J. 1980 Nov;44(5):473–487. doi: 10.1136/hrt.44.5.473. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES